A Phase 3, Multi-center, Randomized, Quadruple-masked, Placebo-controlled Study of Batoclimab for the Treatment of Participants with Active Thyroid Eye Disease (TED)

Protocol No
OPH-IMVT-1401-3202
Phase
III
Summary

This project is being done to see if Batoclimab is safe and helps people with active, moderate to severe thyroid eye disease (TED)

Description
Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories
Eyes and Vision
ClinicalTrials.gov
go to website